Health

Episode Summary

Executive Summary: The episode examines UK health through life expectancy, NHS capacity, GP shortages, cancer outcomes, and productivity. It finds mortality has recovered overall to near pre-pandemic levels, but working-age death rates remain troubling, NHS access is under strain, cancer targets are missed, and healthcare productivity remains disputed yet crucial to future funding pressures.

Main Topics: UK life expectancy and mortality trends (Priority: 5/5): Stuart MacDonald explains that long-run gains in life expectancy have stalled since 2020. Overall mortality has recovered to around pre-pandemic levels, but improvement is weak and uneven across age groups. Age-specific worsening among working-age adults (Priority: 5/5): While over-65 mortality has improved again, death rates for people aged 20-45 were already rising before COVID and remain concerning, with causes including overdoses, suicides, chronic disease, and early cardiovascular deaths. Regional differences across the UK nations (Priority: 4/5): Mortality patterns are broadly similar across nations, but Scotland’s death rates remain much higher than England and Wales, with England and Wales still outperforming Scotland even at the pandemic peak. NHS access pressures and emergency care (Priority: 5/5): The discussion highlights poor ambulance response times and severe A&E delays, showing that emergency care throughput has not recovered to target levels and that winter pressures remain acute. GP workforce and primary care capacity (Priority: 4/5): Nathan Gower reports that promised GP increases did not materialize in England, per-capita GP supply has fallen, and appointment volumes have risen, while primary care’s funding share has only modestly increased. Cancer incidence, survival, and missed targets (Priority: 5/5): Cancer case numbers are rising due to population ageing, while age-standardised rates have flattened or fallen in some areas. Survival is improving, but the UK lags comparable countries and consistently misses treatment timelines. NHS productivity and future funding (Priority: 5/5): Ben Zaranko contrasts ONS and NHS England productivity measures. Both agree the NHS remains below pre-pandemic productivity, and even optimistic productivity gains may only partly offset future spending growth.

Key Arguments: UK life expectancy has stopped improving in a meaningful way since 2020, even though overall mortality has recovered to roughly 2019 levels. The health picture is uneven by age: older people are seeing improvement, but working-age mortality has stagnated or worsened, especially among younger adults. NHS strain is a plausible contributor to worsening mid-life mortality, particularly through disrupted preventive care and weak acute/chronic care delivery. Scotland’s mortality and life expectancy outcomes are materially worse than those in England and Wales, indicating persistent structural differences beyond the pandemic shock. Emergency care performance remains far from targets, with ambulance waits and prolonged A&E delays indicating serious system throughput problems. The number of fully qualified GPs in England fell rather than rose, despite political promises and more trainees, implying workforce retention and workload pressures are outweighing recruitment. Cancer survival is improving, but the UK still underperforms comparable countries because diagnosis and treatment are delayed within the NHS pathway. Healthcare productivity is a major determinant of future spending; even substantial productivity gains may not prevent healthcare from taking a larger share of GDP. There is disagreement over whether NHS productivity has rebounded strongly or remains flat, and the lack of a single trusted measure limits accountability. An ageing population will continue to push demand and costs upward, so policymakers should plan for higher health spending rather than assume productivity alone will solve the problem.

Data Points: UK life expectancy, men (2019): 79.5 years - Stuart MacDonald cites the pre-pandemic level for men in the UK. UK life expectancy, women (2019): 83.2 years - Stuart MacDonald cites the pre-pandemic level for women in the UK. Life expectancy improvement pace in the 1990s and 2000s: Around 15 minutes an hour - Illustrative rate of improvement before the slowdown. Mortality improvement since 2020: Almost no improvement - Stuart MacDonald describes the post-2020 stagnation. Latest provisional mortality data period: Up to late November 2025 - ONS provisional death registrations data referenced by Stuart MacDonald. Category two ambulance target: 18 minutes - Target for serious emergencies such as heart attacks and strokes. Category two ambulance waits before pandemic: Around 20 minutes - Broadly on target in the years before COVID-19. Category two ambulance wait peak: 90 minutes - Peak reached in December 2022. Current category two ambulance waits: 40 to 50 minutes; 32 minutes in October - Recovery has occurred but remains well above target. A&E 12-hour waits before pandemic: Almost no one waiting that long - Before COVID-19, long waits were rare after admission decisions. A&E 12-hour wait peaks: More than 50,000 people in a month - Three successive winters since 2021 saw monthly peaks above this level. GP workforce pledge: 6,000 additional GPs by 2024 - Boris Johnson government promise from a base of more than 28,000. England fully qualified GPs per 100,000 patients (2015): 52 - Baseline comparison for GP supply. England fully qualified GPs per 100,000 patients (now): 45 - Per-capita GP supply has fallen. GP trainees in England: From 5,000 a year to about 10,000 - Training numbers have doubled, but fully qualified GP totals have not risen accordingly. GP appointments in England (2024 average): 13.5 million per month - Appointments conducted by GPs each month. GP appointments in England (2019 average): 13 million per month - Pre-pandemic comparison. All practice staff appointments in England: 30 million per month - Includes nurses, paramedics, and other staff. All practice staff appointments in England (2019 estimate): 26 million per month - Pre-pandemic estimate. Primary care share of England health budget: Around 9% in late 2010s; 10% in last two years - Includes GPs, dentistry, and pharmacies. Current cancer cases per year: Around 360,000 - Current annual diagnosis volume in the UK. Projected cancer cases per year: Around 500,000 in 10-15 years - Projected rise driven mainly by ageing population. Cancer treatment target in England: 85% within 62 days - Percentage of urgent referrals that should start diagnosis/treatment within target time. Cancer treatment target in Wales: 75% within 62 days - National target quoted in the episode. Cancer treatment target in Scotland and Northern Ireland: 95% within 62 days - National target quoted in the episode. Northern Ireland cancer target performance: 33% within target; over 60 percentage points short - Worst-performing nation on the 62-day target. NHS productivity change in 2020: Down 24% - Pandemic-era collapse in productivity. NHS productivity in 2024 vs pre-pandemic: About 8% below - Both ONS and NHS England estimates roughly agree on this level. NHS productivity target in England: 2% per year - Set as part of the funding settlement with the Treasury. NHS England recent productivity growth estimate: About 2.4%-2.7% per year - NHS England claims productivity is ahead of target. OBR baseline health spending path: About 7% of GDP over the next 50 years - Projected need for health spending growth even without major shocks. Potential fiscal saving from matching wider-economy productivity growth: More than 3% of GDP by the 2070s - If healthcare productivity rose as fast as economy-wide productivity.

Pivotal Quotes: "Life expectancy was increasing by around 15 minutes an hour." — Stuart MacDonald: Describing the rapid pre-slowdown gains in UK life expectancy. "The situation's worse still when we look at the younger working age population." — Stuart MacDonald: Explaining that mortality trends are particularly worrying among adults aged roughly 20 to 45. "Somewhere between three years and never is what you're doing." — Ben Zaranko: Summarizing the gap between NHS England’s optimistic productivity estimate and the ONS’s much flatter view.

Implications: The NHS faces a dual challenge: rising demand from ageing and chronic illness, and capacity/productivity gaps that threaten access and outcomes. Even with reforms, health spending likely needs to rise, so transparent productivity measurement and workforce recovery are essential.